Evidence map›Paper›PMID 27700527›Full record

ArticleIslets2016

The P21-activated kinase PAK4 is implicated in fatty-acid potentiation of insulin secretion downstream of free fatty acid receptor 1.

Valérie Bergeron, Julien Ghislain, Vincent Poitout

Open access · bronzeAbstract read
In one paragraph

Article in Islets, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Metabolic and Molecular Amplification of Insulin Secretion.Advances in anatomy, embryology, and cell biology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. The Pancreatic β-Cell: The Perfect Redox System.Antioxidants (Basel, Switzerland) · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Valérie Bergerona Montreal Diabetes Research Center, CRCHUM , QC , Canada.
Julien Ghislaina Montreal Diabetes Research Center, CRCHUM , QC , Canada.
Vincent Poitouta Montreal Diabetes Research Center, CRCHUM , QC , Canada.
Diabetes Canada · CA

Funding

CIHR MOP 86545
6 · The paper itself

Abstract

Free fatty acid receptor 1 (FFA1/GPR40) plays a key role in the potentiation of glucose-stimulated insulin secretion by fatty acids in pancreatic β cells. We previously demonstrated that GPR40 signaling leads to cortical actin remodeling and potentiates the second phase of insulin secretion. In this study, we examined the role of p21 activated kinase 4 (PAK4), a known regulator of cytoskeletal dynamics, in GPR40-dependent potentiation of insulin secretion. The fatty acid oleate induced PAK4 phosphorylation in human islets, in isolated mouse islets and in the insulin secreting cell line INS832/13. However, oleate-induced PAK4 phosphorylation was not observed in GPR40-null mouse islets. siRNA-mediated knockdown of PAK4 in INS832/13 cells abrogated the potentiation of insulin secretion by oleate, whereas PAK7 knockdown had no effect. Our results indicate that PAK4 plays an important role in the potentiation of insulin secretion by fatty acids downstream of GPR40.

Indexed as

AnimalsCell LineGlucoseHumansInsulinInsulin-Secreting CellsInsulin SecretionIslets of LangerhansMiceMice, KnockoutOleic Acidp21-Activated KinasesPhosphorylationReceptors, G-Protein-CoupledRNA, Small InterferingSignal TransductionFFAR1 protein, humanGlucoseInsulinOleic Acidp21-Activated KinasesPAK4 protein, humanReceptors, G-Protein-CoupledRNA, Small InterferingFatty acidsfree fatty acid receptor 1G protein-coupled receptor 40Insulin secretionP21-activated kinase

Identifiers

PMID27700527
PMCPMC5161145
OpenAlexW2529301266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.